Atlas Trials

Liver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies

Clinical trial NCT02556372 · COMPLETED

Trial details

NCT number
NCT02556372
Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autoimmune Hepatitis
Start date
2016-04-30
Primary completion
2019-01-21
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.